Synthesis and pharmacological evaluation of novel derivatives of anti- inflammatory drugs with increased antioxidant and anti-inflammatory activities

Drug Development Research

Volumn 47, Issue 1, 1999, Pages 9-16

  Kourounakis, Angeliki P ^a   Galanakis, Dimitrios ^a   Tsiakitzis, Karyofillis ^a   Rekka, Eleni A ^a   Kourounakis, Panos N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cysteamine; Inflammation; Oxidative stress; Ulcerogenicity

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DICLOFENAC; IBUPROFEN; INDOMETACIN; N (2 THIOLETHYL) 2 METHYL 2 [4 (2 METHYLPROPYL)PHENYL]ACETAMIDE; REACTIVE OXYGEN METABOLITE; TOLFENAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DERIVATIZATION; DRUG EFFECT; DRUG SYNTHESIS; ENZYME INHIBITION; LIPID PEROXIDATION; LIPOPHILICITY; NONHUMAN; OXIDATIVE STRESS; RAT; STOMACH ULCER;

EID: 0032975088     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199905)47:1<9::AID-DDR2>3.0.CO;2-9     Document Type: Article

References (43)

1. Bacq ZM, Alexander P. 1961. Chemical protection against X-and gamma-rays. In: Fundamentals of radiobiology, 2nd ed. Oxford: Pergamon Press. p 457-483.
2. Bannwarth B, Netter P, Pourel J, Royer RJ, Gaucher A. 1989. Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed Pharmacother 43(2):121-126.
3. Bannwarth B, Netter P, Lapicque F, Pere P, Thomas P, Gaucher A. 1990. Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Relationship to analgesic activity. Eur J Clin Pharmacol 38(4):343-346.
4. Bragt PC, Bansberg JI, Bonta IL. 1980. Anti-inflammatory effects of free radical scavengers and antioxidants. Further support for proinflammatory roles of endogenous hydrogen peroxide and lipid peroxides. Inflammation 4:289-299.
5. Braun JE, Sarquis F, Lafleur MV, Retel J. 1996. Effect of the sulfhydryl compound cysteamine on gamma-radiation-induced mutations in double-stranded M13 DNA. Mutat Res 364:171-182.
6. Breitner JCS. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47:401-411.
7. Butterfield DA. 1996. Commentary: Alzheimer's disease: a disorder of oxidative stress. Alzheimer Dis Rev 1:68-70.
8. Dianzani MU, Torrielli MV, Paradisi L, Franzone FS. 1978. Influence of antioxidants and oxygen scavengers on experimental inflammatory processes. Eur J Rheumatol Inflamm 1:187-196.
9. Eichenberger K, Bohni P, Winterhalter KH, Kawato S, Richter C. 1982. Microsomal lipid peroxidation causes an increase in the order of the membrane lipid domain. FEBS Lett 142(1):59-62.
10. Fraisse L, Verhac J-B, Roche B, Rascle MC. 1993. Long chain-substituted uric acid and 5,6-diaminouracil derivatives as novel agents against free radical processes: synthesis and in vitro activity. J Med Chem 36:1465-1473.
11. Gyires K. 1992. Are all "cytoprotective" drugs gastroprotective? Acta Physiol Hung 80(1-4):247-255.
12. Gyires K, Hermecz I, Knoll J. 1989. The effect of some anti-ulcer agents on the early vascular injury of gastric mucosa induced by ethanol in rats. Acta Physiol Hung 73(2-3):149-154.
13. Hadjipetrou-Kourounakis L, Rekka E, Kourounakis A. 1992. Suppression of adjuvant induced disease (AID) by a novel analgesic opioid agonist which also possesses antioxidant activity. Ann NY Acad Sci 650:19-25.
14. Haenen GRMM, Vermeulen NPE, Timmerman H, Bast A. 1989. Effect of thiols on lipid peroxidation in rat liver microsomes. Chem Biol Interact 71:201-212.
15. Halliwell B. 1990. How to characterise a biological antioxidant. Free Radic Res Commun 9:1-32.
16. Halliwell B. 1991. Drug antioxidant effects. Abasis for drug selection? Drugs 42(4):569-605.
17. Halliwell B, Gutteridge JMC. 1989. Chronic inflammation and the autoimmune disease. In: Halliwell B, Gutteridge JMC, editors. Free radicals in biology and medicine. Oxford: Oxford University Press. p 422-438.
18. Halliwell B, Gutteridge JMC. 1991. Free radicals in biology and medicine, 2nd ed.
19. Hansch C, Leo A. 1979. Substituent constants for correlation analysis in chemistry and biology. New York: John Wiley & Sons.
20. Insel PA. 1995. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill. p 617-657.
21. Kalaria RN, Cohen DL, Premkumar DRD. 1996. Cellular aspects of the inflammatory response in the Alzheimer's disease. Neurodegeneration 5:497-503.
22. Kappus H. 1987. Oxidative stress in chemical toxicity. Arch Toxicol 60:144-149.
23. Kettle AJ, Gedye CA, Winterbourn CC. 1993. Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidases. Biochem Pharmacol 45:2003-2010.
24. Kourounakis PN, Rekka E. 1987. Interactions of ethanol with drugs; Effect on drug activity, metabolism and hepatic functions. A comparative study with known microsomal/enzyme inducers. Sci Pharm 55:49-55.
25. Kourounakis AP, Rekka E, Kourounakis PN. 1997. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity. J Pharm Pharmacol 49:938-942.
26. McCormack K. 1994. The spinal actions of non-steroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 47(Suppl 5):28-47.
27. Moilanen E, Kankaahranta H. 1994. Tolfenamic acid and leukotriene synthesis inhibition. Pharmacol Toxicol 75(Suppl 2):60-63.
28. Moilanen E, Alanko J, Seppala E, Vapaatato H. 1988. Effects of anti-rheumatic drugs on leukotriene B4 and prostanoid synthesis in human PMN. Agents Actions 24(3-4):387-394.
29. Naik SR, Kalyanpur S, Sheth UK. 1972. Effects of anti-inflammatrory drugs on glutathione levels and liver succinic dehydrogenase activity in carrageenin edema and cotton pellet granuloma in rats. Biochem Pharmacol 21(4)511-516.
30. Parola M, Paradisi L, Torrielli M. 1984. Non-steroidal anti-inflammatory agents and hepatic lipid peroxidation in normal- and carrageenin-treated rats. Res Commun Chem Pathol Pharmacol 45(1):37-53.
31. Prescott LF, Park J, Sutherland GR, Smith IJ, Proudfoot AT. 1976. Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning. Lancet 2(7977):109-113.
32. Ratty AK, Sunamoto J, Das NP 1988. Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochem Pharmacol 37:989-995.
33. Rekka E, Kolstee J, Timmerman H, Bast A. 1989. The effect of some H2-receptor antagonists on rat hepatic miscrosomal cytochrome P-450 and lipid peroxidation in vitro. Eur J Med Chem 24:43-54.
34. Rekka EA, Psarras N, Kourounakis PN. 1995. The involvement of tolfenamic acid, mefenamic acid and nimesulide in free radical processes. Pharm Sci 1:483-486.
35. Rekka EA, Kourounakis AP, Kourounakis PN. 1996. Investigation of the effect of chamazulene on lipid peroxidation and free radical processes. Res Commun Mol Pathol Pharmacol 92(3):361-364.
36. Rome LH, Lands WEM. 1975. Structural requirements for time dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci USA 72:4863-4865.
37. Salim AS. 1992. Role of sulfhydryl-containing agents in the healing of erosive gastritis and chronic gastric ulceration in the rat. J Pharm Sci 81(1):70-73.
38. Schmid E, Figala V, Roth D, Ullrich V. 1993. Antioxidant and neutrophil-inhibiting properties of new 2-O-methyl-6-(alkylthio)ascorbic acid derivatives. J Med Chem 36:4021-4029.
39. Shanbhag VR, Crider AM, Gokhale R, Harpalani A, Dick RM. 1992. Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity and gastrointestinal toxicity. J Pharm Sci 81(2):149-154.
40. Steinhauer HB, Hertting G. 1981. Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. Eur J Pharmacol 69 (2):199-203.
41. Szabo S, Trier JS, Frankel PW. 1981. Sulfhydryl compounds may mediate gastric cytoprotection. Science 214(4517):200-202.
42. Tanaka J, Yuda Y. 1996. Lipid peroxidation in gastric mucosal lesions induced by indomethacin in rat. Biol Pharm Bull 19(5)716-720.
43. Ursini E Barsacchi R, Pelosi G, Benassi A. 1989. Oxidative stress in the rat heart: studies on low-level chemiluminescence. J Biolumin Chemilumin 4(1):241-244.